Skip to main content
. 2020 Nov 6;60:344–351. doi: 10.1016/j.amsu.2020.10.044

TABLE 4.

Comparison between the three studied groups regarding the percentage of positive immunohistochemical expression of all antibodies in the appendiceal submucosa nerve plexus.


Grupo 1
Grupo 2
Grupo 3

Mediadores N % N % N % p
IL-1 53 0,0 24 0,0 44 0,0
PGE2 4 8,2 2 10,0 8 22,9 0,165*
CD8 0 0,0 1 4,3 4 15,4 0,012*
G3 > G1
TNFα
Synaptophysin 12 26,7 4 16,7 12 42,9 0,105
Enolase 27 57,7 16 69,6 18 69,2 0,554
S-100 protein 34 73,9 12 50,0 21 77,8 0,062
PGP-9.5 33 70,2 3 13,0 3 8,1 < 0,001*
G1 > (G2 = G3)
Tryptase 1 2,1 0 0,0 1 2,7 1000*
VIP 33 68,8 18 81,8 13 54,2 0,131
GIP
VEGF 30 62,5 18 85,7 13 54,2 0,069

N: Total appendices; %: Percentage of positive immunohistochemical expression for each antibody, indicating the presence of its corresponding mediator.

Group 1 (G1): macro- and microscopic normal appendices of patients with clinical and complementary diagnostic exams of acute appendicitis.

Group 2 (G2): inflamed appendices of patients with clinical and complementary diagnostic exams of acute appendicitis.

Group 3 (G3): normal appendices of patients with ascending colon adenocarcinoma submitted to right colectomy.

GIP: gastrin inhibitor peptide; Tryptase: mast cell-related tryptase, VEGF: growth factor of.vascular endothelium; VIP: intestinal vasoactive peptide; TNFα: tumor necrosis factor alpha; IL-1: interleukin 1; PGE2:prostaglandin E2; PGP 9.5: gene-protein product 9.5; CD8: CD8 T lymphocytes.

p: significance by Pearson's chi-square test; *: significance by Fisher's exact test.